Clinical Trials Sponsored by National Cancer Centre, Singapore

Total 15400 results

National Cancer Centre, Singapore
Samsung Medical Center; Singapore General Hospital

Terminated

Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma

Lymphoma, B-Cell, Marginal Zone

Singapore
National University, Singapore
National Cancer Centre, Singapore

Unknown

Accessible Cancer Care to Enable Support for Survivors Programme (ACCESS)

Breast Cancer | Gynecologic Cancer | Survivorship

Singapore
National Cancer Centre, Singapore

Recruiting

Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG) (ENABLE-SG)

Neoplasms

Singapore
National Cancer Centre, Singapore

Recruiting

A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer

Cervix Cancer | Image, Body

Singapore
National Cancer Centre, Singapore

Recruiting

Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma

Colorectal Cancer | Pancreatic Adenocarcinoma

Singapore
National Cancer Centre, Singapore

Recruiting

Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project (IMPACT)

Solid Tumor

Singapore
National Cancer Centre, Singapore

Active, not recruiting

Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma

HepatoCellular Carcinoma

Singapore
National Cancer Centre, Singapore

Terminated

Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC

Non-small Cell Lung Cancer | Leptomeningeal Disease | Central Nervous System Metastases

Singapore
National Cancer Centre, Singapore

Terminated

Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin (ORION-01)

Epithelial Ovarian Cancer

Singapore
National Cancer Centre, Singapore

Completed

Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Singapore
National Cancer Centre, Singapore

Active, not recruiting

Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma

Retroperitoneal Sarcoma

Singapore
National Cancer Centre, Singapore

Active, not recruiting

Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC

Head and Neck Cancer

Singapore
National Cancer Centre, Singapore

Completed

Use of Regorafenib in Recurrent Epithelial Ovarian Cancer

Ovarian Neoplasms

Singapore
National Cancer Centre, Singapore

Completed

PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery (PROGRESS)

Non-small Cell Lung Cancer

Singapore
National Cancer Centre, Singapore

Completed

Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma

Peripheral T-cell Lymphoma

Singapore
National Cancer Centre, Singapore

Completed

Perioperative Immunonutrition for Patients Undergoing CRS and HIPEC

Peritoneal Metastases

Singapore
National Cancer Centre, Singapore

Completed

Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses

Breast Cancer

Singapore
National Cancer Centre, Singapore

Unknown

Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer

Prostate Cancer

Singapore
National Cancer Centre, Singapore

Unknown

Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy

Prostate Cancer

Singapore
National Cancer Centre, Singapore

Completed

Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid Surgery

Thyroid Diseases

Singapore
National Cancer Centre, Singapore

Completed

Irinotecan in Treating Asian Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Singapore
National Cancer Centre, Singapore

Completed

Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas

Sarcoma

Singapore
National Cancer Centre, Singapore

Terminated

Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma (Gifox-B)

Extranodal NK-T-CELL LYMPHOMA

Singapore
National Cancer Centre, Singapore

Terminated

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Palmar-plantar Erythrodysesthesia | Dermatologic Complications

Singapore
National Cancer Centre, Singapore

Terminated

AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

Singapore
National Cancer Centre, Singapore

Completed

Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer

Non-Small Cell Lung Cancer

Singapore
National Cancer Centre, Singapore

Terminated

Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery

Breast Cancer

Singapore
National Cancer Centre, Singapore

Recruiting

Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers (DURIOME)

Diet, Food and Nutrition

Singapore
National Cancer Centre, Singapore

Recruiting

Treatment Individualisation by EBV Stratification in Nasopharyngeal Carcinoma: a Prospective Observational Study

Nasopharyngeal Carcinoma

Singapore
National Cancer Centre, Singapore

Recruiting

Using QPOP to Predict Treatment for Sarcomas and Melanomas

Melanoma | Sarcoma

Singapore
National Cancer Centre, Singapore

Recruiting

PIPAC for Peritoneal Metastases

Peritoneal Metastases

Singapore
National Cancer Centre, Singapore

Recruiting

Telegenetics or In-Person Genetic Counselling

Genetic Counselling

Singapore
National Cancer Centre, Singapore

Active, not recruiting

PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers

Salivary Gland Tumor | Rare Malignant Neoplasm

Singapore
National Cancer Centre, Singapore

Active, not recruiting

Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO

Sarcoma | Lymphoma | Carcinoma | Cancer

Singapore
National Cancer Centre, Singapore

Unknown

Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases

Colorectal Cancer | Peritoneal Metastases

Singapore
National Cancer Centre, Singapore

Completed

A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

HER 2 Positive Advanced Gastric Cancer

Singapore
National Cancer Centre, Singapore

Completed

Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Liver Cancer

Singapore
Singapore General Hospital
National University Hospital, Singapore; National Cancer Center Singapore,... and other collaborators

Withdrawn

Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL (DuRIANS)

EBV Related Non-Hodgkin's Lymphoma | Primary CNS Lymphoma | Primary Testicular Lymphoma

Singapore
National University Hospital, Singapore
National Cancer Centre, Singapore

Unknown

A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Gastric Cancer

Singapore
National University, Singapore
Singapore General Hospital; National Cancer Centre, Singapore

Recruiting

A Pilot Tele-rehabilitation Trial for Breast Cancer Survivors

Breast Cancer Female

Singapore
National Cancer Centre, Singapore
Singapore General Hospital

Recruiting

Molecular Profiling Project

Non-Small Cell Lung Cancer | Lung Cancer

Thailand, Singapore, Hong Kong, Brunei Darussalam, India, Malaysia
Singapore General Hospital
National Cancer Centre, Singapore

Completed

Study to Explore Post Surgical Outcomes Using Point-of-Gaze, Electromyography and Elastography of the SCM

Head and Neck Cancer

Singapore
National University Hospital, Singapore
National Cancer Centre, Singapore

Unknown

Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer

ErbB2-Positive Stage I-III Breast Cancer

Singapore
National Cancer Centre, Singapore
National University of Singapore

Terminated

Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer (DOT)

Breast Neoplasms

Singapore
National Cancer Centre, Singapore
Singapore General Hospital

Completed

Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC

Hepatocellular Carcinoma Resectable

Singapore
Singapore General Hospital
National Cancer Centre, Singapore

Completed

The Impact of Multimodality Treatment on Physical Functions and Quality of Life in Patients With Head and Neck Cancer

Head and Neck Cancer

Singapore
National Cancer Centre, Singapore
Singapore General Hospital

Terminated

A Study Into the Effect of Seprafilm in Open Total Thyroidectomy

Thyroid Carcinoma

Singapore
National Cancer Centre, Singapore
National University Hospital, Singapore; Johns Hopkins Singapore

Terminated

Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer

Non-Small Cell Lung Cancer

Singapore
National University of Singapore
National University Hospital, Singapore; National Cancer Centre, Singapore

Completed

Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer Survivors

Quality of Life | Oncology | Breast Cancer Survivors | Symptom Management | Mindfulness Based Cognitive Therapy

Singapore
National Cancer Centre, Singapore
Novartis

Terminated

Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer

Gastric Cancer | Colorectal Cancer

Singapore

Clinical Trials Sponsored by National Cancer Centre, Singapore

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations